본문 바로가기
  • Home

Screening and isolation of antibacterial proteinaceous compounds from flower tissues: Alternatives for treatment of healthcare-associated infections

Renato Goulart de Almeida 1 Simoni Campos Dias 1 Osmar Nascimento Silva 1 Elizabete de Souza Cândido 1 João Suender Moreira 1 Dianny Elizabeth Jimenez Jojoa 1 Diego Garcês Gomes 1 Mirna de Souza Freire 2 Pedro Henrique de Miranda Bürgel 1 Nelson Gomes de Oliveira Júnior 1 Jorge William Arboleda Valencia 3 Octávio Luiz Franco 2

1Universidade Catolica
2Programa de Pós-Graduação em Ciências Ge
3Universidad del Atlántico

ABSTRACT

Healthcare-associated infection represents a frequent cause of mortality that increases hospital costs. Due to increasing microbial resistance to antibiotics, it is necessary to search for alternative therapies. Consequently, novel alternatives for the control of resistant microorganisms have been studied. Among them, plant antimicrobial protein presents enormous potential, with flowers being a new source of antimicrobial molecules. In this work, the antimicrobial activity of protein-rich fractions from flower tissues from 18 different species was evaluated against several human pathogenic bacteria. The results showed that protein-rich fractions of 12 species were able to control bacterial development. Due its broad inhibition spectrum and high antibacterial activity, the protein-rich fraction of Hibiscus rosa-sinensis was subjected to DEAE-Sepharose chromatography, yielding a retained fraction and a non-retained fraction. The retained fraction inhibits 29.5% of Klebsiella pneumoniae growth, and the non-retained fraction showed 31.5% of growth inhibition against the same bacteria. The protein profile of the chromatography fractions was analyzed by using SDS-PAGE, revealing the presence of two major protein bands in the retained fraction, of 20 and 15 kDa. The results indicate that medicinal plants have the biotechnological potential to increase knowledge about antimicrobial protein structure and action mechanisms, assisting in the rational design of antimicrobial compounds for the development of new antibiotic drugs.

Citation status

* References for papers published after 2023 are currently being built.